Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Hong Haiyu Pharmaceutical Technology is a professional contract research organization (CRO) and regulatory affairs consultancy based in Beijing, China. Established in 2004, the company provides end-to-end services for drug development, including pharmaceutical R&D consulting, clinical trial management, and NMPA registration. Their expertise covers a broad range of therapeutic products, including chemical drugs, biologicals, and traditional Chinese medicines. Hong Haiyu is particularly well-regarded for its ability to guide international pharmaceutical companies through the complexities of the Chinese regulatory environment. The company also offers specialized services such as generic drug consistency evaluation and import drug license applications. By bridging the gap between research and regulatory approval, Hong Haiyu plays a vital role in the commercialization of new therapies in the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hong Haiyu.